Botulinum toxin type A treatment in children with cerebral palsy: evaluation of treatment success or failure by means of goal attainment scaling

K Desloovere, V Schörkhuber, K Fagard… - european journal of …, 2012 - Elsevier
BACKGROUND: There is considerable variability in the amount of response to BTX-A
treatment between and within patients with cerebral palsy (CP). AIMS: The purpose of this …

Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat‐treatment study

MR Delgado, A Tilton… - … Medicine & Child …, 2021 - Wiley Online Library
Aim To assess the efficacy and safety of repeat abobotulinumtoxinA injections in reducing
upper limb spasticity in children with cerebral palsy (CP). Method This was a double‐blind …

Management of upper limb dysfunction in children with cerebral palsy: a systematic review

RN Boyd, ME Morris, HK Graham - European Journal of …, 2001 - Wiley Online Library
Effective use of the upper limb can impact on educational outcomes, participation in
activities of daily living and vocational options for many children with cerebral palsy (CP) …

Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.

RA Ade-Hall, AP Moore - The Cochrane database of systematic …, 2000 - europepmc.org
Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Botulinum toxin type B improves the speed of reaching in children with cerebral palsy and arm dystonia: an open-label, dose-escalation pilot study

TD Sanger, SN Kukke… - Journal of child …, 2007 - journals.sagepub.com
Seven children between 2 and 15 years of age with cerebral palsy and upper extremity
dystonia were enrolled in an open-label, dose-escalation pilot clinical trial of botulinum toxin …

Impairment, disability, and satisfaction outcomes after lower-extremity botulinum toxin A injections for children with cerebral palsy

MA Fragala, ME O'neil, KJ Russo… - Pediatric Physical …, 2002 - journals.lww.com
Purpose: The purpose of this study was to document impairment, disability, and parent
satisfaction outcomes for children with cerebral palsy who received botulinum toxin A (BtA) …

Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity

AMO Bakheit, S Severa, A Cosgrove… - … Medicine and Child …, 2001 - cambridge.org
Botulinum toxin A (BTX-A) is widely used in the management of muscle spasticity in children.
However, at present the dose of BTX-A for a given patient is selected empirically. The aim of …

Botulinum toxin type A injections in the spastic upper extremity of children with hemiplegia: child characteristics that predict a positive outcome

D Fehlings, M Rang, J Glazier… - European Journal of …, 2001 - Wiley Online Library
Evidence is increasing to suggest that botulinum toxin type A (BTX‐A) plays a role in the
management of upper extremity spasticity in the paediatric population. However, little …

Upper-limb injections of botulinum toxin-A in children with cerebral palsy: a critical review of the literature and clinical implications for occupational therapists

BJ Hoare, C Imms - The American journal of occupational …, 2004 - research.aota.org
This paper provides a review of the research literature that reports on the effectiveness of
botulinum toxin-A (BtA) to reduce tone and improve functional use of the upper limbs of …

Effects of leg muscle botulinum toxin A injections on walking in children with spasticity‐related cerebral palsy: a systematic review

U Ryll, C Bastiaenen, ROB De Bie… - … Medicine & Child …, 2011 - Wiley Online Library
Aim To assess treatment effects of botulinum toxin type A (BoNT‐A) on walking of children
with leg spasticity due to cerebral palsy (CP) compared with usual care. Method We …